PHK
EGRX

Point72 Hong Kong’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Point72 Hong Kong’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-771
Closed -$34K – 2511
2022
Q2 		$34K Buy
+771
New +$35.4K ﹤0.01% 1449
2022
Q1 		– Sell
-1,208
Closed -$62K – 2440
2021
Q4 		$62K Buy
+1,208
New +$62.6K ﹤0.01% 1292
2020
Q2 		– Sell
-186
Closed -$9K – 1485
2020
Q1 		$9K Buy
+186
New +$9.33K ﹤0.01% 710
2019
Q1 		– Sell
-33
Closed -$1K – 1336
2018
Q4 		$1K Buy
+33
New +$1.7K ﹤0.01% 826

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Hong Kong's EGRX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 771 shares — an estimated $34K sold.

Point72 Hong Kong first reported a position in EGRX in Q4 2018 and held it in 4 quarters. The position peaked at $62K in Q4 2021. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 771 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $34K.
  • Point72 Hong Kong first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
  • Point72 Hong Kong's Eagle Pharmaceuticals, Inc. position peaked at $62K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.